Hjem › Diffust intrinsisk pontin gliom › Texas
Diffust intrinsisk pontin gliom kliniske forsøg i Texas
11 studier for Diffust intrinsisk pontin gliom søger deltagere på steder i Texas.
Byer i Texas
Officiel studietekst (engelsk)
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Texas Children's Hospital, Houston
RekruttererFase 2
12 Months – 39 Years · Alle køn · Opdateret 21. sep. 2026 · NCT06838676CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- Cook Children's Medical Center, Fort Worth
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
RekruttererFase 1/2
12 Months – 21 Years · Alle køn · Opdateret 11. sep. 2026 · NCT04870944Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
- The University of Texas M. D. Anderson Cancer Center, Houston
RekruttererFase 1
36 Months · Alle køn · Opdateret 9. sep. 2026 · NCT07076498Targeted Pediatric High-Grade Glioma Therapy
- Texas Children's Hospital, Houston
RekruttererObservationsstudie
12 Months – 39 Years · Alle køn · Opdateret 8. sep. 2026 · NCT05839379Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Children's Medical Center, Dallas
RekruttererFase 1/2
Op til 26 år · Alle køn · Opdateret 3. sep. 2026 · NCT06465199Study of Olutasidenib and Temozolomide in HGG
- Texas Children's Hospital, Houston
RekruttererFase 2
Alder 12 til 39 · Alle køn · Opdateret 1. sep. 2026 · NCT06161974PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Texas Children's Hospital, Houston
RekruttererFase 2
Alder 3 til 39 · Alle køn · Opdateret 24. aug. 2026 · NCT05096481C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
- Texas Children's Hospital, Houston
RekruttererFase 1
12 Months – 25 Years · Alle køn · Opdateret 3. aug. 2026 · NCT04099797Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Texas Children's Hospital, Houston
RekruttererTidlig fase 1Frivillige med god helbredstilstand velkomne
Alder 1 til 21 · Alle køn · Opdateret 29. jun. 2026 · NCT06333899Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Texas Children's Hospital, Houston
RekruttererFase 2
12 Months – 39 Years · Alle køn · Opdateret 29. maj 2026 · NCT05843253A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- Texas Children's Hospital, Houston
RekruttererTidlig fase 1
Op til 21 år · Alle køn · Opdateret 18. mar. 2026 · NCT04655404Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.